Literature DB >> 18790363

Epidemiology and diagnosis of acute kidney injury.

Michael Zappitelli1.   

Abstract

The development of recent standardized definitions of acute kidney injury (AKI) has allowed us to begin understanding pediatric AKI epidemiology and risk factors and to stratify outcome by AKI severity. AKI incidence will vary with illness severity of the population studied and definition type, ranging from less than 1% when need for dialysis is used to 82% when less conservative definitions (such as > or =1.5 times baseline serum creatinine) are used to define AKI. The most common AKI causes are secondary, such as sepsis, nephrotoxic medication, and ischemia, each leading to acute tubular necrosis (ATN). Children undergoing cardiopulmonary bypass surgery, stem cell transplantation, or with multiple organ dysfunction syndrome are at high risk for these events. A key feature in diagnosis and management includes identifying the presence of ATN versus a reversible hypovolemic state because patients with ATN may quickly develop fluid overload with overaggressive fluid therapy, requiring dialytic removal. Despite advances in acute pediatric dialysis therapy and in overall care of critically ill children, severe AKI still is associated with a high mortality rate, necessitating more research in early AKI identification and therapeutic trials.

Entities:  

Mesh:

Year:  2008        PMID: 18790363     DOI: 10.1016/j.semnephrol.2008.05.003

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  22 in total

Review 1.  Renal angina: an emerging paradigm to identify children at risk for acute kidney injury.

Authors:  Rajit K Basu; Lakhmir S Chawla; Derek S Wheeler; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2011-10-20       Impact factor: 3.714

2.  Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery.

Authors:  Chirag R Parikh; Prasad Devarajan; Michael Zappitelli; Kyaw Sint; Heather Thiessen-Philbrook; Simon Li; Richard W Kim; Jay L Koyner; Steven G Coca; Charles L Edelstein; Michael G Shlipak; Amit X Garg; Catherine D Krawczeski
Journal:  J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 10.121

3.  Approaches to the Management of Acute Kidney Injury in Children.

Authors:  Rajit K Basu; Derek S Wheeler
Journal:  Recent Pat Biomark       Date:  2011

Review 4.  Enabling innovative translational research in acute kidney injury.

Authors:  Abolfazl Zarjou; Paul W Sanders; Ravindra L Mehta; Anupam Agarwal
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

5.  Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression.

Authors:  Rajit K Basu; Susan Hubchak; Tomoko Hayashida; Constance E Runyan; Paul T Schumacker; H William Schnaper
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

Review 6.  Epidemiology of acute kidney injury in children worldwide, including developing countries.

Authors:  Norbert Lameire; Wim Van Biesen; Raymond Vanholder
Journal:  Pediatr Nephrol       Date:  2016-06-15       Impact factor: 3.714

Review 7.  Acute kidney injury: can we improve prognosis?

Authors:  Christine W Hsu; Jordan M Symons
Journal:  Pediatr Nephrol       Date:  2010-04-09       Impact factor: 3.714

8.  Preoperative plasma FGF23 levels predict acute kidney injury in children: results of a pilot study.

Authors:  Farah N Ali; Amanda Hassinger; Heather Price; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2013-01-13       Impact factor: 3.714

Review 9.  Sepsis and Acute Kidney Injury.

Authors:  Beliz Bilgili; Murat Haliloğlu; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-12-01

10.  Kidney Outcomes 5 Years After Pediatric Cardiac Surgery: The TRIBE-AKI Study.

Authors:  Jason H Greenberg; Michael Zappitelli; Prasad Devarajan; Heather R Thiessen-Philbrook; Catherine Krawczeski; Simon Li; Amit X Garg; Steve Coca; Chirag R Parikh
Journal:  JAMA Pediatr       Date:  2016-11-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.